Amwill Health Care Ltd (AMWILL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Amwill Health Care Ltd on NSE and BSE, with an AI summary of each filing.
Declaration of an Interim Dividend of Rs.0.50 per equity share of face value Rs.10 each, i.e @5% of the paid up value per share, for financial year 2026-27.
Dividend · 23 Oct 2026, 7:58 pm
Amwill Health Care Reports H1 FY27 Results and Declares ₹0.50 Interim Dividend Amwill Health Care Limited reported revenue from operations of ₹2,262.86 lakhs for the half-year ended 30th Sep'26, up from ₹2,120.50 lakhs in the corresponding period last year. Net profit stood at ₹367.39 lakhs compared to ₹387.40 lakhs YoY, translating to a basic and diluted EPS of ₹1.84 versus ₹1.94. Additionally, the Board approved an interim dividend of ₹0.50 per equity share (5% of face value ₹10) for FY27, fixing 30th Oct'26 as the record date.
The Board has fixed Friday, October 30, 2026 as the "Record date" for ascertaining the names of the members entitled to receive the Interim Dividend.
Dividend · 23 Oct 2026, 7:33 pm
Amwill Health Care H1 FY27 Results and Interim Dividend Declaration Amwill Health Care reported revenue from operations of ₹2,262.86 lakhs for the half year ended 30th Sep'26, up 6.71% YoY from ₹2,120.50 lakhs in H1 FY26. Total income reached ₹2,461.58 lakhs versus ₹2,260.30 lakhs YoY. Net profit stood at ₹367.39 lakhs compared to ₹387.40 lakhs in the prior-year period, resulting in an EPS of ₹1.84. Additionally, the Board declared an interim dividend of ₹0.50 per share (5% on face value ₹10) for FY27, setting 30th Oct'26 as the record date.
Approval of unaudited Financial Results of the Compnay for the half year ended September 30, 2026, for the financial year 2026-27.
Financial Result · 23 Oct 2026, 7:24 pm
Amwill Health Care Reports H1 FY27 Results and Interim Dividend Amwill Health Care approved its unaudited financial results for the half year ended 30th Sep'26. Revenue from operations rose 6.71% YoY to ₹2,262.86 lakhs from ₹2,120.50 lakhs in H1 FY26, while net profit declined 5.16% YoY to ₹367.39 lakhs against ₹387.40 lakhs. Basic and diluted EPS stood at ₹1.84 compared to ₹1.94 YoY. The board declared an interim dividend of ₹0.50 per equity share (5% of FV ₹10), fixing the record date as 30th Oct'26. Net worth reached ₹8,325.15 lakhs.
Outcome of the meeting of the Board of Directors held on October 23, 2026: Approval of Unaudited Financial Results of the Company for the half year ended September 30, 2026; Declaration ....
Outcome · 23 Oct 2026, 7:12 pm
Amwill Health Care H1 FY27 Results and Interim Dividend Declaration Amwill Health Care reported revenue from operations of ₹2,262.86 lakhs for the half year ended 30th Sep'26, up 6.71% YoY from ₹2,120.50 lakhs in H1 FY26. Total income stood at ₹2,461.58 lakhs compared to ₹2,260.30 lakhs in the prior-year period. Net profit for the period came in at ₹367.39 lakhs versus ₹387.40 lakhs in H1 FY26, yielding a basic EPS of ₹1.84. Additionally, the board declared an interim dividend of ₹0.50 per equity share (5% of face value ₹10), setting the record date as 30th Oct'26.
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Intimation · 23 Oct 2026, 5:30 am
Amwill Health Care Board Meeting on 23rd Oct'26 for H1 Results, Interim Dividend Amwill Health Care Limited has scheduled a Board of Directors meeting on 23rd Oct'26 to consider and approve the unaudited financial results for the half year ended 30th Sep'26 (H1 FY27). The board will also consider the declaration of an interim dividend for equity shareholders. The trading window for designated persons, closed since 1st Oct'26, will reopen 48 hours post the announcement of financial results.
Intimation under Regulation 30 of the Sebi (listing Obligation and disclosure Requirements) Regulations,2015- Grant of license/regulatory approval for import of folicolor-oxidative hair colour.
Others (Uncategorized) · 10 Oct 2026, 6:44 pm
Amwill Health Care Secures CDSCO Import Approval for FoliColor Hair Color Amwill Health Care Limited received an import registration certificate (RC/COS-007631) from the Central Drugs Standard Control Organization (CDSCO) on 9th Oct'26. The new licence permits the import and commercial sale of FoliColor - Oxidative hair colour (Black variant) in India. Valid for five years from 8th Oct'26 to 7th Oct'31, the regulatory approval expands the company's product portfolio and is expected to drive top-line revenue growth. The counterparty/supplier is not a related party.
Intimation for approval of investment in units of Vivriti Vihaan Trust, a scheme of an Alternative Investment Fund registeed under SEBI and in units of Neo Income plus Fund III, a scheme ....
Others (Uncategorized) · 25 Sept 2026, 7:13 pm
Amwill Health Care Approves ₹3.00 Cr AIF Investments Amwill Health Care Limited’s Investment Committee approved aggregate investments of up to ₹3.00 Cr on 25th Sep'26, funded entirely through internal accruals. The allocation comprises up to ₹1.50 Cr in units of Vivriti Vihaan Trust and up to ₹1.50 Cr in Neo Income Plus Fund III (a scheme of Neo Credit Alternatives Investment Trust), both SEBI-registered Alternative Investment Funds. Scheduled for deployment in upcoming months, the non-related party investments aim to drive financial growth and support operational objectives.
Intimation regarding Re-appointment of Manging Directors for the further term of five years pursuant to the approval of the Members at the 9th AGM of Amwill Health Care Limited.
Change in Management · 15 Aug 2026, 12:20 am
Submission of E voting results along with consolidated Scrutinizer''s Report for the 9th AGM of Amwill Health Care Limited.
Annual General Meeting · 15 Aug 2026, 12:13 am
Outcome of the proceedings of 09th AGM of Amwill Health Care Limited held on August 14, 2026 .
Annual General Meeting · 14 Aug 2026, 9:29 pm
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 regarding investment in different segments.
Others (Uncategorized) · 08 Aug 2026, 7:01 pm
Amwill Health Care Approves New Multi-Asset Treasury Investment Strategy Amwill Health Care’s Investment Committee on 08 Aug'26 approved a new treasury strategy to deploy surplus cash from internal accruals into a multi-asset framework. The plan includes aggregate investment limits of ₹15 Cr in private credit/AIFs, ₹10 Cr in government and corporate debt securities, and ₹2 Cr in listed equities and IPOs. Additionally, the company has set a combined ceiling of ₹3 Cr for invoice discounting platforms and another ₹3 Cr for mutual funds via SIPs to enhance risk-adjusted returns.
Announcment under Regulation 30(LODR)- Change in Mangement PDf is attched.
Change in Management · 08 Aug 2026, 6:55 pm
Amwill Health Care Re-appoints Key MDs and Sets AGM Date Amwill Health Care's board, on Jul 17, '26, approved the re-appointment of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for five-year terms, effective from Jan 27, '27 to Jan 26, '32. The board also approved the FY26 Annual Report and will convene its 9th Annual General Meeting (AGM) via video conference on Aug 14, '26. The record date for AGM e-voting eligibility is set for Aug 08, '26, with the e-voting window open from Aug 11 to Aug 13, '26.
Intimation of approval for opening of fixed Deposit of Rs. 2 crores with Vysya Co-operative Bank.
Others (Uncategorized) · 23 Jul 2026, 11:49 pm
Amwill Health Care Approves ₹2 Crore Fixed Deposit Investment Amwill Health Care's Investment Committee approved opening a ₹2 crore Fixed Deposit with Vysya Co-operative Bank on 23 Jul'26. The investment, funded from internal accruals, is intended to support the company's long-term growth strategy. The transaction does not involve any related parties.
Notice of the Ninth Annual General Meeting for the Financial Year 2025-26 is attched.
Annual General Meeting · 23 Jul 2026, 12:49 am
The Record date for the purpose of Final Dividend For FY 2026 will be August 08, 2026.
Dividend · 17 Jul 2026, 10:03 pm
Amwill Health Care Reappoints MDs; Sets AGM and Record Date The Board of Directors on 17 Jul'26 approved the re-appointment of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for five-year terms, effective 27 Jan'27. The company will hold its 9th Annual General Meeting (AGM) via video conference on 14 Aug'26. The record date for the final dividend for FY26 and AGM voting eligibility has been set for 08 Aug'26. The board also approved the Annual Report for FY26. Remote e-voting for the AGM will be open from 11 Aug'26 to 13 Aug'26.
Outcome Of The Meeting Of Board Of Directors Of Amwill Health Care Limited Held On July 17,2026.
Others (Uncategorized) · 17 Jul 2026, 9:59 pm
Amwill Health Care Board Approves MD Reappointments and AGM Schedule The Board approved the reappointments of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for five years, commencing 27 Jan'27 to 26 Jan'32, subject to shareholder approval. The company will convene its 9th AGM via video conference on 14 Aug'26. The record date for determining shareholder eligibility for e-voting is set for 08 Aug'26. The remote e-voting window will be open from 11 Aug'26 to 13 Aug'26. The Board also approved the Annual Report for FY26.
Intimation of approval for investment in MO Alternates India Credit Excellence Fund - I (Category II AIF) and Goverment Securities.
Others (Uncategorized) · 20 Jun 2026, 12:01 am
Amwill Health Care To Invest INR 4 Crore In AIF and Government Securities Amwill Health Care's Investment Committee, on 19 Jun'26, approved a total investment of INR 4 Cr from internal accruals. The company will invest up to INR 3 Cr in MO Alternates India Credit Excellence Fund – I, a Category II AIF, to support financial growth. An additional INR 1 Cr will be invested in Government Securities (G-Sec) and related products to advance its long-term growth strategy. The transactions do not involve any related parties.
Pursuant to regulation 32 of Sebi (LODR) Regulations 2015, we here by confirm that there is no deviation or variation in utilisation of proceeds of the IPO fund from the object stated in ....
Others (Uncategorized) · 30 May 2026, 8:45 pm
Amwill Health Care FY26 Results and Final Dividend Declaration Amwill Health Care's Board approved FY26 audited results on 30 May'26 and recommended a final dividend of ₹0.50 per share (5% of face value). FY26 net profit rose 6.4% YoY to ₹1,142.13 lakhs on revenue of ₹4,549.23 lakhs, up 12.1% YoY. Basic EPS for FY26 stood at ₹5.71 vs. ₹6.63 last year. The auditor's report noted a cybersecurity incident on 18 Feb'26 which required reconstruction of accounting data, but issued an unmodified opinion. All IPO proceeds have been fully utilized.
Approval of audited Financial Results for half year and FY 2026
Financial Result · 30 May 2026, 8:30 pm
Amwill Healthcare Board Approves FY26 Results and Recommends Dividend Amwill Healthcare's board approved audited results for the year ended 31-Mar'26 and recommended a final dividend of ₹0.50 per share (5%). For FY26, revenue from operations grew 12.1% YoY to ₹4,549.23 lakhs, while net profit rose 6.4% YoY to ₹1,142.13 lakhs. The full-year basic EPS stood at ₹5.71, down from ₹6.63 in FY25. Auditors issued an unmodified opinion but noted an 'Emphasis of Matter' regarding a Feb'26 cybersecurity incident that required partial reconstruction of accounting records.
Recommendation of final dividend @ 5% i.e Rs. 0.50 per equity share face value of Rs. 10 each.
Dividend · 30 May 2026, 8:20 pm
Amwill Health Care FY26 Results: Profit Up 6.4%, Recommends 5% Dividend Amwill Health Care's Board approved FY26 results on 30-May-26, reporting a 6.4% YoY rise in net profit to ₹1,142.13 lakhs on revenue of ₹4,549.23 lakhs, up 12.1% YoY. H2FY26 profit stood at ₹754.73 lakhs. The Board recommended a final dividend of ₹0.50 per share (5% of face value). The auditor's report noted an "Emphasis of Matter" regarding a Feb'26 cyber incident that required reconstruction of some accounting data from 30-Sep-25 to 18-Feb-26, but issued an unmodified opinion on the financials.
Outcome of the meeting of the Board of Directors held on May 30, 2026: Approval of Audited Financial Results for Half Year & FY 2026; recommendation of dividend @ 5%, i.e.; Rs.0.50- per ....
Outcome · 30 May 2026, 8:14 pm
Amwill Health Care Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 2,429 (+39.4% YoY | +14.5% QoQ) ■ EBITDA: 888 (+215.9% YoY | +116.1% QoQ) ■ EBITDA Margin (%): 36.6 (+2044 bps YoY | +1719 bps QoQ) ■ PAT: 755 (+79.1% YoY | +94.8% QoQ) ■ EPS (INR): 3.77 (+50.2% YoY | +94.3% QoQ)
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Intimation · 30 May 2026, 5:30 am
Amwill Health Care Board to Consider FY26 Results and Dividend on May 30 Amwill Health Care's Board of Directors will meet on 30 May'26 to consider and approve audited financial results for the half-year and financial year ended 31 Mar'26. The board will also consider recommending a final dividend for FY26, subject to shareholder approval. In line with insider trading regulations, the trading window for designated persons has been closed since 01 Apr'26 and will reopen 48 hours after the results are announced.
Please find the attached intimation under Regulation 30 of Listing Regulation.
Others (Uncategorized) · 08 Apr 2026, 12:00 am
Amwill Health Care Updates on IT Security Incident and Data Restoration Following a security incident on 18th Feb'26, Amwill Health Care has contained the threat and remediated its systems. The incident resulted in the loss of Unpublished Price Sensitive Information (UPSI) data maintained in its Structured Digital Database (SDD) for the period 31st Jul'25 to 18th Feb'26. The company reports that all affected data has been successfully reconstructed and re-entered into the system. A Practicing Company Secretary has certified that all UPSI entries in the SDD have been completed and updated.
Please find the attached intimation under Regulation 30 of Listing Regulations.
Others (Uncategorized) · 19 Feb 2026, 1:42 am
Amwill Health Care Reports Cybersecurity Breach Amwill Health Care disclosed a cybersecurity incident on 18 Feb'26, impacting all account-related data from 30 Sep'25 onwards. The company confirmed that data required for regulatory compliance remains secure and preserved. Management, with cybersecurity experts, has isolated affected systems and initiated containment, remediation, and recovery protocols. A detailed investigation is currently underway to assess the full impact, with further updates to be provided as necessary. The incident was reported under Regulation 30 of SEBI Listing Regulations.
Re appointment of SPR& Co, Chartered Accountants ("SPR") as the internal Auditor of the Company for Financial Year 2025-26.
Change in Auditor · 09 Feb 2026, 7:00 pm
Amwill Health Care Re-appoints SPR & Co as Internal Auditor for FY26 Amwill Health Care's Board of Directors, on the recommendation of the Audit Committee, has approved the re-appointment of SPR & Co, Chartered Accountants (Firm Reg. No. 009784S) as the company's Internal Auditor. The appointment, effective from 09 Feb'26, is for the financial year 2025-26. This decision ensures continuity in the company's internal audit function. SPR & Co is a management consulting firm with a team of over 400 professionals, providing integrated services in accounting, IT, and Cyber Law.